Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping (MAESTRO)

This study has been completed.
Sponsor:
Collaborators:
Myung In Pharmaceutical Company
Yonsei University
Information provided by (Responsible Party):
KyungYul Lee, Gangnam Severance Hospital
ClinicalTrials.gov Identifier:
NCT01174693
First received: August 3, 2010
Last updated: March 16, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)